According to the approval under ANVISA’s new rules, collagen supplements in Brazil that deliver a daily dose of only 2.5 grams of Verisol become the first to be allowed to use skin health claims, said the company in a release.
Verisol is composed of pure collagen peptides that have been specifically developed to provide the highest possible efficacy in human skin, stated Gelita. They stimulate fibroblast cells in the dermis which substantially increases the renewal and repair of collagen, elastin and proteoglycans – all of which are essential for providing skin elasticity. As a result, the epidermis is supported from within and skin sagging is prevented.
The efficacy of the ingredient has been reported in six different studies specific to the product, involving nearly 500 participants, added the company. Reported benefits relate to skin elasticity, wrinkles, fine lines, cellulite, nails, and hair.
“The evaluation process put our product to a high standard test, and we are pleased that the Agency recognised the safety and efficacy of Verisol,” said Dr Stephan Hausmanns, Gelita’s VP of Health & Nutrition. “This success also demonstrates GELITA’s continuous leadership within the collagen market, emphasising that not all collagen peptides have an equal efficacy. VERISOL is so far the only collagen peptide to prove its bioactive benefits for skin health in the Brazilian market.”
The regulatory framework
ANVISA introduced specific regulations for food supplements in 2018, when manufacturers were called to prove the efficacy of their products. The regulatory framework was designed to reduce the information gap in the Brazilian market, especially related to marketing claims that lack scientific proof.
The Brazilian Agency is building a positive list of approved ingredients and health claims, and companies have a transition period to adapt existing products, while new products have to be within the scope of the new rules.